Pal S - Search Results

1

Experiences with adverse drug reaction reporting by patients: an 11-country survey.

van Hunsel F, Härmark L, Pal S, Olsson S, van Grootheest K. van Hunsel F, et al. Among authors: pal s. Drug Saf. 2012 Jan 1;35(1):45-60. doi: 10.2165/11594320-000000000-00000. Drug Saf. 2012. PMID: 22149419 Review.

2

Adverse Drug Reaction Reporting in Africa and a Comparison of Individual Case Safety Report Characteristics Between Africa and the Rest of the World: Analyses of Spontaneous Reports in VigiBase®.

Ampadu HH, Hoekman J, de Bruin ML, Pal SN, Olsson S, Sartori D, Leufkens HG, Dodoo AN. Ampadu HH, et al. Among authors: pal sn. Drug Saf. 2016 Apr;39(4):335-45. doi: 10.1007/s40264-015-0387-4. Drug Saf. 2016. PMID: 26754924 Free PMC article.

3

Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda.

Ndagije H, Nambasa V, Namagala E, Nassali H, Kajungu D, Sematiko G, Olsson S, Pal S. Ndagije H, et al. Among authors: pal s. Drug Saf. 2015 Apr;38(4):395-408. doi: 10.1007/s40264-015-0277-9. Drug Saf. 2015. PMID: 25749663 Free PMC article.

4

Pharmacovigilance activities in 55 low- and middle-income countries: a questionnaire-based analysis.

Olsson S, Pal SN, Stergachis A, Couper M. Olsson S, et al. Among authors: pal sn. Drug Saf. 2010 Aug 1;33(8):689-703. doi: 10.2165/11536390-000000000-00000. Drug Saf. 2010. PMID: 20635827

5

WHO strategy for collecting safety data in public health programmes: complementing spontaneous reporting systems.

Pal SN, Duncombe C, Falzon D, Olsson S. Pal SN, et al. Drug Saf. 2013 Feb;36(2):75-81. doi: 10.1007/s40264-012-0014-6. Drug Saf. 2013. PMID: 23329541 Free PMC article.

6

The monitoring medicines project: a multinational pharmacovigilance and public health project.

Pal SN, Olsson S, Brown EG. Pal SN, et al. Drug Saf. 2015 Apr;38(4):319-28. doi: 10.1007/s40264-015-0283-y. Drug Saf. 2015. PMID: 25829215 Free PMC article.

7

Pharmacovigilance in resource-limited countries.

Olsson S, Pal SN, Dodoo A. Olsson S, et al. Among authors: pal sn. Expert Rev Clin Pharmacol. 2015;8(4):449-60. doi: 10.1586/17512433.2015.1053391. Epub 2015 Jun 3. Expert Rev Clin Pharmacol. 2015. PMID: 26041035 Review.

8

Drug bulletins: independent information for global use.

Olsson S, Pal S. Olsson S, et al. Among authors: pal s. Lancet. 2006 Sep 9;368(9539):903-4. doi: 10.1016/S0140-6736(06)69351-3. Lancet. 2006. PMID: 16962866 No abstract available.

9

Specific features of medicines safety and pharmacovigilance in Africa.

Isah AO, Pal SN, Olsson S, Dodoo A, Bencheikh RS. Isah AO, et al. Among authors: pal sn. Ther Adv Drug Saf. 2012 Feb;3(1):25-34. doi: 10.1177/2042098611425695. Ther Adv Drug Saf. 2012. PMID: 25083223 Free PMC article. Review.

10

Teaching pharmacovigilance: the WHO-ISoP core elements of a comprehensive modular curriculum.

Beckmann J, Hagemann U, Bahri P, Bate A, Boyd IW, Dal Pan GJ, Edwards BD, Edwards IR, Hartigan-Go K, Lindquist M, McEwen J, Moride Y, Olsson S, Pal SN, Soulaymani-Bencheikh R, Tuccori M, Vaca CP, Wong IC. Beckmann J, et al. Among authors: pal sn. Drug Saf. 2014 Oct;37(10):743-59. doi: 10.1007/s40264-014-0216-1. Drug Saf. 2014. PMID: 25171836 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,451 results

Search Page